{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:19:50Z","timestamp":1767611990798,"version":"build-2065373602"},"reference-count":24,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,3,19]],"date-time":"2007-03-19T00:00:00Z","timestamp":1174262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:sec>\n                    <jats:label\/>\n                    <jats:p>Associate Editor<\/jats:p>\n                    <jats:p>Michael G. Wyllie<\/jats:p>\n                    <jats:p>Editorial Board<\/jats:p>\n                    <jats:p>Ian Eardley, UK<\/jats:p>\n                    <jats:p>Jean Fourcroy, USA<\/jats:p>\n                    <jats:p>Sidney Glina, Brazil<\/jats:p>\n                    <jats:p>Julia Heiman, USA<\/jats:p>\n                    <jats:p>Chris McMahon, Australia<\/jats:p>\n                    <jats:p>Bob Millar, UK<\/jats:p>\n                    <jats:p>Alvaro Morales, Canada<\/jats:p>\n                    <jats:p>Michael Perelman, USA<\/jats:p>\n                    <jats:p>Marcel Waldinger, Netherlands<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To assess the influence of vardenafil on treatment satisfaction in men with erectile dysfunction (ED) and their female partners.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS<\/jats:title>\n                    <jats:p>This was a pooled analysis of three randomized, double\u2010blind, placebo\u2010controlled, 12\u2010week studies of flexible\u2010dose vardenafil vs placebo, in men with ED for \u22656\u2003months (n\u2003=\u2003788) and their untreated female partners. Measures of efficacy included the Treatment Satisfaction Scale (TSS), International Index of Erectile Function, Erectile Function domain (IIEF\u2010EF), and Sexual Encounter Profile (SEP) questions 2 and 3 (SEP\u20102, \u2018Were you able to insert your penis into your partner\u2019s vagina?\u2019; and SEP\u20103, \u2018Did your erection last long enough for you to have sexual intercourse?\u2019). In addition to the overall analysis, there was a subgroup analysis for potential moderators of response, e.g. whether patients who had undergone previous phosphodiesterase type 5 (PDE\u20105) treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      At baseline, least\u2010squares (LS) mean scores for all TSS domains were similar in the vardenafil and placebo groups. After 12\u2003 weeks of treatment, vardenafil significantly improved the LS mean score for all domains compared with placebo, among both patients and their female partners (\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u20030.0001, \u2018last\u2019\u2010observation\u2010carried\u2010 forward analysis). Absolute between\u2010 group differences in LS mean TSS scores (vardenafil\u2003\u2212\u2003placebo) were: ease of erection (patients 23.4, partners 24.9), erectile function satisfaction (36.7 and 32.9), pleasure from sexual activity (23.0, 23.7), satisfaction with orgasm (27.6, 21.8), confidence to complete sexual activity (28.2, 32.5), and satisfaction with medication (37.4, 35.6). The benefits of vardenafil were greater in men who had undergone previous PDE\u20105\u2010inhibitor treatment and men aged &lt;45\u2003years, while the overall pattern of benefit was similar in all examined subgroups. There were significant benefits with vardenafil in all other variables (IIEF\u2010EF scores and positive response rates to SEP\u20102 and SEP\u20103).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>ConClusions<\/jats:title>\n                    <jats:p>Vardenafil significantly improved treatment satisfaction in men with ED, and in their partners. The results provide further evidence of the validity of the TSS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2006.06737.x","type":"journal-article","created":{"date-parts":[[2007,3,19]],"date-time":"2007-03-19T07:16:12Z","timestamp":1174288572000},"page":"849-859","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The COUPLES\u2010project: a pooled analysis of patient and partner treatment satisfaction scale (TSS) outcomes following vardenafil treatment"],"prefix":"10.1111","volume":"99","author":[{"given":"Raymond C.","family":"Rosen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Beneke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Homering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Evers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,3,19]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.00173.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-2838(03)00215-X"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/00926230490262366"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.00118.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.05.008"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2004.08.001"},{"key":"e_1_2_7_8_2","first-page":"711","volume-title":"Erectile Dysfunction. 1st International Consultation on Erectile Dysfunction.","author":"Andersson KE","year":"2000"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01049.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.04043.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2004.05161.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.00150.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.1.79"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2004.04025.x"},{"key":"e_1_2_7_15_2","first-page":"2687","article-title":"Penetration and maintenance of erection with vardenafil: a time\u2010from\u2010dosing analysis","volume":"12","author":"Valiquette L","year":"2005","journal-title":"Can J Urol"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.00119.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.00147.x"},{"volume-title":"Presented at the European Association of Urology (EAU) Congress","year":"2006","author":"Edwards D","key":"e_1_2_7_18_2"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2004.01.014"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jama.1993.03510010089036","article-title":"NIH Consensus Conference. Impotence","volume":"270","author":"NIH Consensus Development Panel on Impotence.","year":"1993","journal-title":"JAMA"},{"key":"e_1_2_7_21_2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0022-5347(18)34282-4","article-title":"Female partners of men with erectile dysfunction treated with sildenafil citrate report greater satisfaction and enjoyment from sexual intercourse: a multicentre, randomized, double\u2010blind, placebo\u2010controlled trial","volume":"173","author":"Heiman JR","year":"2005","journal-title":"J Urol"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/00926230600575314"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2006.00310.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.20111.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.01.007"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2006.06737.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2006.06737.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:18:10Z","timestamp":1761751090000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2006.06737.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,19]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1111\/j.1464-410X.2006.06737.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2006.06737.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"type":"print","value":"1464-4096"},{"type":"electronic","value":"1464-410X"}],"subject":[],"published":{"date-parts":[[2007,3,19]]},"assertion":[{"value":"2007-03-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}